Type of Posting: Notice of Intent to Revise
Posting Date: 09-Aug-2022
Targeted Official Date: 01-May-2024; USP-NF 2024 Issue 1
Expert Committee: Small Molecules 4
In accordance with the Rules and Procedures of the Council of Experts, this is to provide notice that the Small Molecules 4 Expert Committee intends to omit the Ioxilan monograph.
USP may propose to omit a monograph from the USP-NF if the article is no longer marketed in the United States and where the monograph is not necessary to serve a public health need. Based on evaluation of the monograph, the Expert Committee proposes to omit the Ioxilan monograph.
USP Ioxilan Related Compound A RS, associated with this monographs, is currently unavailable. USP does not intend to develop a replacement lot for USP Ioxilan Related Compound A RS in anticipation of the omission of this monograph.
It is anticipated that the proposed omission will be published in Pharmacopeial Forum 48(6) [Nov-Dec 2022] pursuant to the Rules and Procedures. The comment period for this omission ends on January 31, 2023. In the absence of any adverse comments, the proposed omission will become official on May 1, 2024.
Should you have any questions, please contact Jasmine McFarland, Scientist III (jasmine.mcfarland@usp.org)
CN-23-002-00